Positives

• Patients with POTS taking oral DDAVP commonly report tachycardia easing within two hours of dosing, with measurable drops in symptom burden PMC.
• Roughly 4 in 10 POTS patients who tolerate DDAVP report improvement in dizziness, presyncope, palpitations, and anxiety Innovations in Cardiac Rhythm Management.
• Some POTS patients describe DDAVP as a useful pre-event "pill in the pocket" before situations like flights or long meetings Dr Sanjay Gupta Cardiologist.

Negatives

• One POTS patient on a stack of orthostatic-intolerance drugs reported that desmopressin “didn’t help me stand” but did allow her a full night’s sleep, which she credited to reduced overnight urination and steadier morning blood volume Phoenix Rising.
  
  
• A patient reported that desmopressin, fludrocortisone, and IV saline all made her feel worse immediately on trial, and she discontinued all three — a reminder that blood-volume-expanding therapies do not universally help POTS Phoenix Rising.
  
  

Hurdles & Side Effects

• Desmopressin is a synthetic vasopressin analogue originally approved for central diabetes insipidus and nocturnal enuresis, and its main risk in POTS patients is hyponatremia from over-retention of free water; forum members warn that sodium and potassium should be tracked throughout treatment, not just at initiation Phoenix Rising.